Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Lakeland Regional Medical Center, Inc. v. Astellas US, LLC et al
Case Number:
8:10-cv-02008
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Beasley Allen
- Bradley Arant
- Carlton Fields
- Finnegan
- Fish & Richardson
- Leydig Voit
- Peterson & Myers
- Sidley Austin
Companies
Sectors & Industries:
-
May 03, 2013
11th Circ. Denies Cert. Appeal In $867M Astellas Antitrust Suit
The 11th Circuit refused Thursday to let a Florida hospital appeal in hopes of winning certification of an $867 million antitrust class action accusing Astellas Pharma Inc. of improperly requiring use of its Adenoscan drug with patented cardiac tests, but the provider intends to soldier on alone.
-
January 14, 2013
Fla. Hospital Again Denied Cert. In $867M Drug Antitrust Suit
A Florida federal judge on Monday again refused to grant class certification of an $867 million antitrust class action accusing Astellas Pharma Inc. of improperly requiring use of its Adenoscan drug with patented cardiac tests, saying there was no legal or factual reason to reconsider the denial.
-
October 10, 2012
Fla. Hospital Wants Class Cert. In $867M Drug Antitrust Suit
A Florida hospital on Tuesday again requested certification of an $867 million antitrust class action accusing Astellas Pharma Inc. of improperly requiring use of its Adenoscan drug with patented cardiac tests, saying an earlier denial misread the U.S. Supreme Court's ruling in Illinois Brick Co. v. Illinois.
-
September 26, 2012
Astellas Skirts $867M Antitrust Suit Over Heart Test Drug
A federal judge ruled Monday that a Florida hospital didn't have standing to file an $867 million antitrust class action accusing Astellas Pharma Inc. of abusing a patent monopoly to force health care providers to use only an Astellas-brand cardiac testing drug.
-
July 26, 2011
Astellas Stress Test Antitrust Suit Survives
A Florida federal judge on Monday refused to dismiss Lakeland Regional Medical Center Inc.'s antitrust class action against affiliates of Astellas Pharma Inc. over patented cardiac stress test procedures, saying Lakeland's complaint cleared several hurdles including U.S. Supreme Court precedent.
-
September 14, 2010
Astellas Hit With Antitrust Suit Over Stress Test System
A Florida hospital has filed a putative class action against U.S.-based affiliates of Astellas Pharma Inc., alleging the Japanese pharmaceutical company’s promotion of its patented cardiac stress test procedures has violated antitrust laws.